The Development and Quality Assurance Team at CCRM is responsible for advancing regenerative medicine technologies from laboratory research to clinical application. This team ensures the efficient development of innovative therapies, particularly in cell and gene therapy, while also overseeing quality control and compliance to meet regulatory standards. By integrating scientific expertise with strategic oversight, they play a critical role in bringing breakthrough regenerative treatments to patients.
View all